Coronary artery disease Trials in Kansas City, United States
Conditions / Coronary artery disease / Kansas City, United States
Research into Coronary artery disease spans multiple therapeutic approaches and trial phases.
79 total trials for this combination
Showing top 10 of 79 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01524276 | Product Surveillance Registry | RECRUITING | — |
| NCT00066898 | ARISE - Aggressive Reduction of Inflammation Stops Events | UNKNOWN | PHASE3 |
| NCT01471522 | International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) | COMPLETED | NA |
| NCT00584818 | Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease | COMPLETED | PHASE2 |
| NCT00977938 | The Dual Antiplatelet Therapy Study (DAPT Study) | COMPLETED | PHASE4 |
| NCT01751906 | ABSORB III Randomized Controlled Trial (RCT) | COMPLETED | NA |
| NCT01524276 | Product Surveillance Registry | RECRUITING | — |
| NCT01106534 | XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort | COMPLETED | PHASE4 |
| NCT00557921 | Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) | TERMINATED | PHASE3 |
| NCT00088179 | Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II) | COMPLETED | PHASE3 |